期刊文献+

糖尿病肾病患者血清炎症因子与肾素血管紧张素系统的监测及意义 被引量:1

Significance of serum inflammatory factors and reninangiotensin system in patients with diabetic nephropathy
下载PDF
导出
摘要 目的探讨炎症因子和肾素血管紧张素系统改变在糖尿病肾病发病和治疗中的作用。方法 112例首诊的糖尿病患者分别在入院第2日和治疗后第10周门诊复查时测定IL-6、CRP、PRA、AngⅡ及尿白蛋白排泄率。结果 112例糖尿病患者中,正常白蛋白尿组58例、微量白蛋白尿组37例和临床白蛋白尿组17例的IL-6、CRP、PRA、AngⅡ水平均依次增高(P<0.05)。IL-6、CRP、PRA、AngⅡ水平和尿白蛋白排泄率均呈正相关(P<0.05)。治疗10周后,IL-6、CRP、PRA及AngⅡ均较治疗前下降(P<0.05);并且IL-6、CRP、PRA及AngⅡ水平的下降以治疗显效组最为明显(P<0.05)。结论炎症与肾素血管紧张素系统的过度激活以及二者相互影响可能在糖尿病肾病发病中起重要作用,并且糖尿病肾病的治疗效果也和炎症与肾素血管紧张素系统激活的改善状况有关。 [ Objective] To investigate the changes of inflammatory factors and renin-angiotensin system in diabetic nephropathy and access the pathogenesis. [Methods] IL-6, CRP, PRA, Ang Ⅱ and urinary albumin excretion rate were determined in 112 patients with diabetes meMtus at the second day in hospital and after 10 weeks of treatment, respectively. [Results] Among 112 diabetes patients, there were 58 patients of normal albuminuria, 37 patients of microalbuminuria, 17 patients of clinical albuminuria. The level of IL-6, CRY, PRA, Ang Ⅱ were increased gradually in this three groups (P 〈0.05). IL-6, CRP, PRA, Ang Ⅱ levels and urinary albumin excretion rate were positively correlated (P 〈0.05). After 10 weeks of treatment, IL-6, CRP, PRA and Ang Ⅱ decreased compared with those before treatment (P 〈0.05); and IL-6, CRP, PRA and Ang Ⅱ were markedly decreased in the markedly group (P 〈0.05). [Conclusion] The excessive activation of inflammation and renin-angiotensin system, as well as the interaction, may play an important role in the pathogenesis of diabetic nephropathy , and the results of the treatment of diabetic nephropathy may related to the improved situation of inflammation and reninangiotensin system activation.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2010年第13期2041-2043,2046,共4页 China Journal of Modern Medicine
关键词 糖尿病肾病 炎症 肾素血管紧张素 发病机制 diabetic nephropathy inflammation renin-angiotensin pathogenesis
  • 相关文献

参考文献10

  • 1American Diabetes Association. Diabetic nephropathy [J]. Diabetes Care, 2003, 26(Suppl 1): S94-S98.
  • 2金波,刘志红,葛永纯,谢红浪,王少凡,伏幼娟,黎磊石.肾活检患者中糖尿病肾病流行病学特点的变迁[J].肾脏病与透析肾移植杂志,2009,18(2):133-139. 被引量:44
  • 3World Health Organization. Definition, diagnosis and classification of diabetes mellitus. Report of a WHO consolation [M]. Geneva: World Health Organization, 1999: 442-443.
  • 4MOGENSEN CE, CHACHATI A, CHRISTENSEN CK, et al. Micro albuminuria: an early marker of renal involvement in diabetics[M]. Uremia Invest, 1986, 9(2): 85-95.
  • 5梁毅堂.糖尿病肾病发病机制的研究进展[J].内科,2009,4(2):286-288. 被引量:8
  • 6DALLA.VESTRA M, MUSSAP M, GALLINA P, et al. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes [J]. J Am Soc Nephrol 2005, 16(Suppl1): 78-82.
  • 7VIDT DG. Inflammation in renal disease[J]. Am J Cardio,l 2006, 97(2): 20-27.
  • 8ABRAHAMIAN H, ENDLER G, EXNERM, et al. Association of low-grade inilammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and different geae-polymorphisms of proinflammatory cytokines[J]. Exp Clin Endocrinol Diabetes, 2007, 115(1): 38-41.
  • 9MIYAZAKI KENICHI, MIYAZAKI MASANOBU, KOJI TAKEHIKO, et al. Renal synthesis of umkinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: Modulation by angiotensin-converting-enzyme inhibitor [J]. Journal of Laboratory and Clinical Medicine, 2004, 144(2): 69-77.
  • 10项金华.血管紧张素转化酶抑制剂联合环氧化酶2抑制剂治疗糖尿病肾病的临床观察[J].中国现代医学杂志,2007,17(6):741-743. 被引量:4

二级参考文献30

共引文献53

同被引文献10

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部